Bicara Q2 FY26 net loss widens 102.4% to $55.44 million
BCAX•Cash position, runway and leadership update
Cash, cash equivalents and marketable securities increased to $497.3 million as of June 30 from $414.8 million at year-end; runway is expected into the first half of 2029.
Ryan Cohlhepp will become CEO on Jan. 1, 2027, while the company targets substantial FORTIFI-HN01 enrollment by year-end and an interim readout in mid-2027.
Second-quarter loss widens as expenses rise
Bicara posted a Q2 net loss of $55.44 million, more than doubled from a $27.39 million loss a year earlier; loss per share widened to $0.82.
R&D expenses climbed to $45.77 million from $24.8 million, due to costs tied to the FORTIFI-HN01 pivotal trial, Phase 1/1b cohorts, and higher personnel costs.
G&A expenses rose to $14.18 million from $7.22 million, on additional personnel costs and professional fees as it prepares for potential commercialization.
